Outcomes of thymoma after multimodal therapy and determinants of survival: A 16-year experience of a tertiary cancer center

BACKGROUND: In this study, we aimed to evaluate the factors that contribute to survival outcomes in patients with thymoma treated with multimodal approaches. METHODS: A total of 203 patients (105 males, 98 females; median age: 49 years; range, 17 to 77 years) with Masaoka-Koga Stage II-IV thymoma be...

Descripción completa

Detalles Bibliográficos
Autores principales: Ak, Naziye, Toker, Alper, Kara, Murat, Özkan, Berker, Ülker, Melike, Kaba, Erkan, Yeğen, Gülçin, Karaman, Şule, Dağoğlu, Nergiz, Kaytan Sağlam, Esra, Oral, Ethem Nezih, Kızır, Ahmet, Bayraktar, Soley, Dişçi, Rian, Ferhatoğlu, Ferhat, Aydın, Esra, Vatansever, Sezai, Eralp, Yeşim, Aydıner, Adnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bayçınar Medical Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762900/
https://www.ncbi.nlm.nih.gov/pubmed/35096446
http://dx.doi.org/10.5606/tgkdc.dergisi.2021.20529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762900/
https://www.ncbi.nlm.nih.gov/pubmed/35096446
http://dx.doi.org/10.5606/tgkdc.dergisi.2021.20529

Ejemplares similares